Contact Us

Global Femtech Market Growth Drivers 2024, Forecast To 2033

25 Sep, 2024

The femtech market is projected to witness rapid expansion, growing from $36.52 billion in 2023 to $41.97 billion in 2024, with a compound annual growth rate (CAGR) of 14.9%. This surge is driven by increased awareness of women's health, a shift towards personalized healthcare, and evolving societal attitudes. By 2028, the market is forecasted to reach $81.24 billion at an impressive CAGR of 18.0%, fueled by advancements in digital health platforms, telehealth services, and a focus on fertility and preventive wellness solutions. Emerging trends include AI-powered health apps, wearable devices, and strategic investments in femtech startups.

Major Driver In The Femtech Market

The integration of Internet of Things (IoT) applications into farm equipment is anticipated to propel the farm machinery and equipment market. As the global population is expected to exceed 9 billion by 2050, farmers seek improved tools and practices to enhance agricultural productivity. The adoption of modern technologies, such as IoT-enabled smart greenhouses, allows for climate monitoring and control without human intervention. IoT sensors provide data on light levels, pressure, humidity, and temperature, automatically adjusting actuators to manage various conditions. This technology aids in increasing production efficiency with reduced labor, thereby driving the farm machinery and equipment market. These advancements shape the market sizes for 2023, 2024, and 2028.

Request A Free Sample Of The Global Femtech Market Report

Femtech Market Competitive Landscape

Totohealth Inc., LifeSense Group, Lumenis Ltd., Maven Clinic, Kindbody Fertility & Women's Health, Flo Health Inc., Minvera Health Inc., Natural Cycles, NURX Inc., BioWink GmbH, Elvie Inc., Nuvo Group LLC, Lia Diagnostics Inc., Bloomlife Inc., Kasha Global Inc., Proov, Athena Feminine Technologies, Ava Science Inc., Joylux Inc., MedAnswers, OCON Healthcare LLC, Flyte by Pelvital, Inne Inc., Tia Health, Gennev, iSono Health Inc., OOVA Inc., Sera Prognostics Inc., Cora Health Inc., HeraMED Inc., Sustain Natural, LactApp Women’s Health, Trak Fertility, Willow Pump Company, Yono Labs, Zava

Key Femtech Market Trend

Advanced technology products are a significant trend in the femtech industry. Companies are focused on developing products that deliver precise results and reduce handling time. For instance, in 2021, Lia, a US-based company, introduced the world’s first flushable and biodegradable pregnancy test device made from plant fibers, which is entirely plastic-free and biodegrades within ten weeks.

Get The Full Global Femtech Market Report

Femtech Market Segmentation

The femtech market covered in this report is segmented –
1) By Type: Devices, Software, Services, Other Types
2) By End Use: Direct-To-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers
3) By Application: Reproductive Health, Pregnancy and Nursing Care, Pelvic and Uterine Healthcare, General Healthcare and Wellness, Other Applications
By Geography:The regions covered in the femtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. North America was the largest region in the femtech market in 2023.

The Femtech Global Market Report 2024 furnishes information about the global femtech market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.